Market Reports Center One Stop Market Reaserch Shop
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2016 Research Report by Market Report Center
SUMMARY Global Markets Direct’ s, ‘ Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2016’ , provides an overview of the Thrombotic Thrombocytopenic Purpura pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thrombotic Thrombocytopenic Purpura, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura and features dormant and discontinued projects. Browse Detail Report With TOC @ https://marketreportscenter.com/reports/276105/thrombotic
Global Markets Direct’ s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’ s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Market Reports Center One Stop Market Reaserch Shop The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
The report provides a snapshot of the global therapeutic landscape of Thrombotic Thrombocytopenic Purpura The report reviews pipeline therapeutics for Thrombotic Thrombocytopenic Purpura by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved Thrombotic Thrombocytopenic Purpura therapeutics and enlists all their major and minor projects The report assesses Thrombotic Thrombocytopenic Purpura therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type The report summarizes all the dormant and discontinued pipeline projects The report reviews latest news related to pipeline therapeutics for Thrombotic Thrombocytopenic Purpura
Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Thrombotic Thrombocytopenic Purpura - Identify potential new clients or partners in the target demographic
Market Reports Center One Stop Market Reaserch Shop - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it’ s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Thrombotic Thrombocytopenic Purpura pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Request A Sample copy of This Report @ https://marketreportscenter.com/reports/276105/thrombotic
Table of Contents Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Thrombotic Thrombocytopenic Purpura Overview 7 Therapeutics Development 8 Pipeline Products for Thrombotic Thrombocytopenic Purpura – Overview 8 Pipeline Products for Thrombotic Thrombocytopenic Purpura – Comparative Analysis 9 Thrombotic Thrombocytopenic Purpura – Therapeutics under Development by Companies 10 Thrombotic Thrombocytopenic Purpura – Therapeutics under Investigation by Universities/Institutes 11 Thrombotic Thrombocytopenic Purpura – Pipeline Products Glance 12 Late Stage Products 12 Clinical Stage Products 13 Early Stage Products 14 Thrombotic Thrombocytopenic Purpura – Products under Development by Companies 15 Thrombotic Thrombocytopenic Purpura – Products under Investigation by Universities/Institutes 16 Thrombotic Thrombocytopenic Purpura – Companies Involved in Therapeutics Development 17 Ablynx NV 17 Biogen, Inc. 18 Glenmark Pharmaceuticals Ltd. 19 Kaketsuken K.K. 20 Lee's Pharmaceutical Holdings Limited 21
Market Reports Center One Stop Market Reaserch Shop Octapharma AG 22 Omeros Corporation 23 Thrombotic Thrombocytopenic Purpura – Therapeutics Assessment 24 Assessment by Monotherapy Products 24 Assessment by Target 25 Assessment by Mechanism of Action 27 Assessment by Route of Administration 29 Assessment by Molecule Type 31 Drug Profiles 33 ARC-15105 - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 BAX-930 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 caplacizumab - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 GBR-600 - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 OMS-721 - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Browse Full Report @ https://marketreportscenter.com/reports/276105/thrombotic
About Us: Market Reports Centeris an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable. Market Reports Center currently has more than 1,20,000 plus titles and 30+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics,
Market Reports Center One Stop Market Reaserch Shop Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Contact Information: Sam Collins Market Reports Center 1-646-883-3044 (US) info@marketreportscenter.com https://marketreportscenter.com http://marketreportscenter.blogspot.in/